Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF). Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia.
Purity:
>95%
CAS Number:
[1638332-55-4]
Target:
CSF-1R|||c-Fms
* VAT and and shipping costs not included. Errors and price changes excepted